Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
2005 1
2007 5
2008 3
2009 5
2010 3
2011 2
2012 1
2014 1
2016 1
2017 1
2018 1
2019 2
2020 1
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Eculizumab in STEC-HUS: a paradigm shift in the management of pediatric patients with neurological involvement.
Wildes DM, Harvey S, Costigan CS, Sweeney C, Twomey É, Awan A, Gorman KM. Wildes DM, et al. Pediatr Nephrol. 2024 Jan;39(1):315-324. doi: 10.1007/s00467-023-06102-w. Epub 2023 Jul 25. Pediatr Nephrol. 2024. PMID: 37491519
Central nervous system (CNS) involvement in Shiga toxin-producing Escherichia coli (STEC)-HUS is associated with increased morbidity and mortality. ...METHODS: A retrospective chart review of patients with CNS involvement in STEC-HUS is managed with su …
Central nervous system (CNS) involvement in Shiga toxin-producing Escherichia coli (STEC)-HUS is associated with increa …
Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: a multinational embedded cluster crossover randomized trial (the HIKO STEC trial).
Freedman SB, Schnadower D, Estes M, Casper TC, Goldstein SL, Grisaru S, Pavia AT, Wilfond BS, Metheney M, Kimball K, Tarr PI; Hyperhydration to Improve Kidney Outcomes in children with Shiga Toxin-producing E. Coli infection (HIKO-STEC) Study Team. Freedman SB, et al. Trials. 2023 May 27;24(1):359. doi: 10.1186/s13063-023-07379-w. Trials. 2023. PMID: 37245030 Free PMC article. Clinical Trial.
BACKGROUND: Shiga toxin-producing E. coli (STEC) infections affect children and adults worldwide, and treatment remain solely supportive. Up to 15-20% of children infected by high-risk STEC (i.e., E. coli that produce Shiga toxin 2) develop hemolytic a …
BACKGROUND: Shiga toxin-producing E. coli (STEC) infections affect children and adults worldwide, and treatment remain solely …
Therapeutic plasma exchange in paediatric nephrology in Ireland.
Wildes DM, Devlin C, Costigan CS, Raftery T, Hensey C, Waldron M, Dolan N, Riordan M, Sweeney C, Stack M, Cotter M, Lynch B, Gorman KM, Awan A. Wildes DM, et al. Ir J Med Sci. 2023 Nov 8. doi: 10.1007/s11845-023-03560-x. Online ahead of print. Ir J Med Sci. 2023. PMID: 37940814
The leading indication was neurological involvement in Shiga toxin-producing Escherichia coli haemolytic uraemic syndrome (STEC-HUS) (n = 29). Complications (minor or major) occurred in 65.5% (n = 38) of patients, with most experiencing minor complications 58 …
The leading indication was neurological involvement in Shiga toxin-producing Escherichia coli haemolytic uraemic syndrome ( …
Province-Wide Review of Pediatric Shiga Toxin-Producing Escherichia coli Case Management.
Freedman SB, Eltorki M, Chui L, Xie J, Feng S, MacDonald J, Dixon A, Ali S, Louie M, Lee BE, Osterreicher L, Thull-Freedman J. Freedman SB, et al. J Pediatr. 2017 Jan;180:184-190.e1. doi: 10.1016/j.jpeds.2016.09.013. Epub 2016 Oct 10. J Pediatr. 2017. PMID: 27745751
OBJECTIVE: To identify the gaps in the care of children infected with Shiga toxin-producing Escherichia coli (STEC), we sought to quantitate care received and management timelines. ...CONCLUSIONS: A significant proportion of children developed HUS following m …
OBJECTIVE: To identify the gaps in the care of children infected with Shiga toxin-producing Escherichia coli (STEC), we …
Contribution and Interaction of Shiga Toxin Genes to Escherichia coli O157:H7 Virulence.
Tarr GAM, Stokowski T, Shringi S, Tarr PI, Freedman SB, Oltean HN, Rabinowitz PM, Chui L. Tarr GAM, et al. Toxins (Basel). 2019 Oct 18;11(10):607. doi: 10.3390/toxins11100607. Toxins (Basel). 2019. PMID: 31635282 Free PMC article.
Escherichia coli O157:H7 is the predominant cause of diarrhea-associated hemolytic uremic syndrome (HUS) worldwide. ...Adjusted for age and symptoms, the HUS incidence of E. coli O157:H7 containing stx2a alone was 4.4% greater (95% confidence interval (CI) -0 …
Escherichia coli O157:H7 is the predominant cause of diarrhea-associated hemolytic uremic syndrome (HUS) worldwide. ...Adjuste …
Trace levels of peptidoglycan in serum underlie the NOD-dependent cytokine response to endoplasmic reticulum stress.
Molinaro R, Mukherjee T, Flick R, Philpott DJ, Girardin SE. Molinaro R, et al. J Biol Chem. 2019 May 31;294(22):9007-9015. doi: 10.1074/jbc.RA119.007997. Epub 2019 Apr 17. J Biol Chem. 2019. PMID: 30996003 Free PMC article.
However, the effect was specific to thapsigargin, as tunicamycin and the subtilase cytotoxin SubAB from Shiga toxigenic Escherichia coli, which induce ER stress by other mechanisms, did not induce cytokine expression. ...
However, the effect was specific to thapsigargin, as tunicamycin and the subtilase cytotoxin SubAB from Shiga toxigenic Esc …
Orchiopexy for intra-abdominal testes: factors predicting success.
Stec AA, Tanaka ST, Adams MC, Pope JC 4th, Thomas JC, Brock JW 3rd. Stec AA, et al. J Urol. 2009 Oct;182(4 Suppl):1917-20. doi: 10.1016/j.juro.2009.03.069. Epub 2009 Aug 20. J Urol. 2009. PMID: 19695613
Of these cases 32 were performed laparoscopically with 96.9% success. One-stage Fowler-Stephens orchiopexy was performed in 27 testes and 2-stage Fowler-Stephens orchiopexy was performed in 37 with success in 63.0% and 67.6%, respectively. Multivariate analysis reve …
Of these cases 32 were performed laparoscopically with 96.9% success. One-stage Fowler-Stephens orchiopexy was performed in 27 testes …
Spoilage and safety characteristics of ground beef treated with lactic acid bacteria.
Hoyle AR, Brooks JC, Thompson LD, Palmore W, Stephens TP, Brashears MM. Hoyle AR, et al. J Food Prot. 2009 Nov;72(11):2278-83. doi: 10.4315/0362-028x-72.11.2278. J Food Prot. 2009. PMID: 19903389 Free article.
Lactic acid bacteria (LAB) can decrease numbers of Escherichia coli O157:H7 and Salmonella in ground beef during storage. ...We conclude that LAB could potentially be added to ground beef in TOP and MAP as a processing intervention for E. coli O157:H7 and Sal …
Lactic acid bacteria (LAB) can decrease numbers of Escherichia coli O157:H7 and Salmonella in ground beef during storage. ...W …
31 results